26 January 2018
: Case report
Hemorrhagic Brain Metastases in a Patient with Anaplastic Lymphoma Kinase (ALK)-Rearranged Invasive Mucinous Adenocarcinoma of the Lung
Rare disease
Mingxia Shi1ABCDEF*, Hongzhi Xu1B, Angela DiPoto Brahmbhatt2BD, Eduardo Gonzalez-Toledo3D, Maria-Magdalena Georgescu1BCDEFDOI: 10.12659/AJCR.906803
Am J Case Rep 2018; 19:99-104
Abstract
BACKGROUND: Invasive mucinous adenocarcinoma (IMA) is a rare variant of adenocarcinoma of the lung. It frequently shows KRAS mutations, while ALK rearrangement is exceedingly rare. We present a case of ALK-rearranged IMA of the lung presenting with an unusual pattern of brain metastases, radiologically mimicking a cavernous angioma.
CASE REPORT: A 44-year-old non-smoker female was first diagnosed with lung right lower lobe IMA with ALK rearrangement. Five years after surgery followed by chemotherapy, she developed a sudden onset headache. Brain imaging revealed a hemorrhagic left frontal mass, suspicious for a cavernous angioma. However, the pathology of the resected lesion showed an ALK-rearranged brain metastasis from the IMA of the lung. Interestingly, the metastases showed perivascular tumor infiltrates, accompanied by focal mural invasion, vascular disruption, and hemorrhage.
CONCLUSIONS: To our knowledge, this is the first reported case of brain metastasis from an ALK-rearranged IMA of the lung. Further investigation of the clinical and pathological characteristics of the ALK-rearranged IMA, including awareness of the possibility for development of brain metastases with tumor-associated vasculopathy and hemorrhage, is warranted.
Keywords: Adenocarcinoma, Mucinous, Gene Rearrangement
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947011
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946427
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946551
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945265
Most Viewed Current Articles
21 Jun 2024 : Case report
94,336
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
51,457
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
28,658
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
23,129
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030